Cellular mechanism for granulocyte-colony stimulating factor in the prevention of graft-versus-host disease in combined bone marrow and peripheral blood transplantation for hematological malignancies: The composition in collection-Reference-Cited by-同舟云学术

Cellular mechanism for granulocyte-colony stimulating factor in the prevention of graft-versus-host disease in combined bone marrow and peripheral blood transplantation for hematological malignancies: The composition in collection

Published:2013-02 Issue:1 Volume:48 Page:3-9
ISSN:1473-0502
Container-title:Transfusion and Apheresis Science
language:en
Short-container-title:Transfusion and Apheresis Science

Author:

Zhang Cheng,Zhang Xi,Chen Xing-Hua

Publisher

Elsevier BV

Subject

Hematology

Reference115 articles.

1. Impact of graft-versus-host disease on survival;Pasquini;Best Prac Res Clin Haematol,2008

2. Long-term survival and late deaths after allogeneic bone marrow transplantation;Socie;N Engl J Med,1999

3. Graft-versus-leukemia reactions after bone marrow transplantation;Horowitz;Blood,1990

4. Current use and outcome of hematopoietic stem cell transplantation: part I—CIBMTR Summary Slides, 2007;Pasquini;CIBMTR Newsl [serial online],2007

5. Twenty-year follow-up of a controlled trial comparing a combination of methotrexate plus cyclosporine with cyclosporine alone for prophylaxis of graft-versus-host disease in patients administered HLA-identical marrow grafts for leukemia;Sorror;Biol Blood Marrow Transplant,2005

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. JAK/STAT signaling pathway inhibitors for leukemia therapeutic potential : a systematic review on in vitro literatures;2024-09-02

2. JAK/STAT as therapeutic signaling pathway in leukemia: a systematic review on in vitro inhibitors;2024-08-06

3. Comparison of Outcomes of Haploidentical Peripheral Blood Stem Cell Transplantation Supported by Third-Party Cord Blood Versus Human Leukocyte Antigen-Matched Sibling Peripheral Blood Stem Cell Transplantation in Hematologic Malignancy Patients;Frontiers in Oncology;2022-07-14

4. Reduced BUCY 2 and G-CSF-primed bone marrow associates with low graft-versus-host-disease and transplant-related mortality in allogeneic HSCT;Annals of Hematology;2017-07-09

5. Human-derived normal mesenchymal stem/stromal cells in anticancer therapies;Journal of Cancer;2017